Medical Policy Vitamin D Assay Testing

Medical Policy Vitamin D Assay Testing

Table of Contents

? Policy: Commercial

? Policy: Medicare

? Authorization Information

? Coding Information ? Description ? Policy History

? Information Pertaining to All Policies ? References ? Endnotes

Policy Number: 746

BCBSA Reference Number: 2.04.135 NCD/LCD: Local Coverage Determination (LCD): Vitamin D Assay Testing (L37535)

Related Policies

None

Policy1 Commercial Members: Managed Care (HMO and POS), PPO, and Indemnity Medicare HMO BlueSM and Medicare PPO BlueSM Members

Measurement of 25-OH Vitamin D (CPT 82306) level is considered MEDICALLY NECESSARY for patients with any of the following conditions:

? Chronic kidney disease stage III or greater ? Cirrhosis ? Hypocalcemia ? Hypercalcemia ? Hypercalciuria ? Hypervitaminosis D ? Parathyroid disorders ? Malabsorption states ? Obstructive jaundice ? Osteomalacia ? Osteoporosis if:

o T score on DEXA scan 3% 10-year probability of hip fracture or 20% 10-year probability of other major

osteoporotic fracture or o FRAX> 3% (any fracture) with T-score ................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download